A Nigerian-British businessman and social media influencer, Igho Ubiribo, underwent five penile enlargement procedures at a Bangkok clinic before his death in March, Thai health authorities have disclosed.
Ubiribo, 43, also known by the names “Tiny,” “Denisi” and “Ego,” died after receiving his latest penile filler treatment while on holiday in Thailand with his wife.
The disclosure followed an inspection of the clinic on September 7 by officials of Thailand’s Department of Health Service Support and the Food and Drug Administration, following a directive from the country’s Minister of Public Health, Pattana Promphat.
According to the authorities, the clinic told investigators that Ubiribo had been receiving the procedures since 2024, with four treatments carried out between 2024 and 2025 before the final one on March 5, 2026.
The last procedure involved the injection of 40cc of filler into his penis. Investigators said the doctor had advised that the treatment be administered in two sessions, but Ubiribo reportedly opted to have it done at once.
The clinic further told officials that the businessman was given post-procedure instructions and was contacted afterwards but did not report any complications. It also said he had signed consent documents before each treatment.
Thai authorities said the events surrounding his death began after he received the final injection and later went for a massage with his wife. He subsequently complained of chest pain and lost consciousness.
He was taken to a private hospital in Bangkok, where doctors suspected a blood clot and planned a CT angiography to examine his blood vessels. However, he became unconscious and had no pulse before the scan could be conducted.
Medical personnel reportedly carried out cardiopulmonary resuscitation for more than 100 minutes without success, and Ubiribo was pronounced dead in the early hours of March 6.
The Thai Department of Health Service Support said it was gathering medical and operational records from the clinic to determine whether proper professional standards were followed.
Its Director-General, Phuwadej Surakhot, said the findings would be forwarded to Thailand’s Medical Council for consideration if necessary.
“We will gather all facts and evidence to proceed according to our authority and submit the case to the Medical Council for a ruling on professional practice standards, in order to ensure fairness to all parties,” Surakhot said.
No malpractice finding has been announced against the clinic so far. However, an earlier UK coroner’s inquest reportedly linked Ubiribo’s death to a pulmonary embolism following the cosmetic treatment.
A postmortem examination also reportedly found material in his lungs consistent with hyaluronic acid, one of the substances used during the procedure.
Following the death, aesthetic medicine and dermatology physician, Dr Mobola Savage, warned that penile fillers should not be regarded as risk-free simply because they do not involve conventional surgery.
She explained that the procedure was a non-surgical form of penile augmentation primarily intended to increase girth, but stressed that it still involved an invasive treatment of an area containing major blood vessels.
The Thai investigation remains ongoing as authorities determine whether the clinic and the medical personnel involved complied with the required medical and professional standards.
